View Report Details
Genetic Testing Market Report -------------------------------2012
View Report Details Executive Summary Genetic testing, which is also known as DNA testing, is the latest innovation in the field of molecular diagnostics. The genetic
testing market segment represents the highest growth opportunity compared to other segments within the molecular diagnostics market. The growth of the market is backed by increasing prevalence of genetic diseases, aging population, and rising awareness. Vast application areas including newborn screening, prenatal and pre implantation testing is also expected to add to the future growth of the market. The technological advancements of genetic testing are expected to break new grounds in the field of personalized medicine as genetic testing helps not only in the better diagnosis of genetic diseases but also aids in selecting the best medication depending on the DNA structure of the patient to ensure superior drug response. Direct to customer (DTC) genetic testing is one of the major trends in the market, which is expected to bring positive changes in the popularity of genetic testing. However, the quality, accuracy, and proper interpretation of test results of DTC genetic testing continue to challenge the future growth of the market. Furthermore, the risk of genetic discrimination and psychological consequences of genetic testing are also expected to hinder the growth of the market in the coming years. The current report analyzes the genetic testing market. It discusses the drivers and challenges prevailing in the genetic testing market. It presents the competitive conditions prevailing in the market, along with the profiles of major players. By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future
growth of the global genetic testing market. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
Strong growth of global genetic testing market on the back of growing prevalence of cancer and increasing availability of genetic tests… In 2007, the market for genetic testing was valued at ……………billion and it registered a CAGR of ……% to reach US$......billion in 2011. Currently, genetic testing………………………………………………. The improving ………………..scenario in the …………………………… ……………………………………………………… is also adding to the growth of the market……………………………………
Global Genetic Testing Market
US$ Billion
Gene therapy involves ………………. Gene therapy can be used to ……………. There were around ………….gene therapy clinical trials in progress during 2011 globally, …… diseases accounted for about …% ……………………………………………………………………………….. ………………………………………………………….
2007
2008
2009
2010
2011
The large-scale ……initiatives, coupled with …….. due to ……. have led to ….. in the availability of ………... Genetic testing was used for approximately …… diseases in …………………………….................. which recorded a CAGR of ….% to reach …… diseases in 2010. New technologies, ………………………………………………………………
Worldwide Gene Therapy Clinical Trials by Disease
No. of Diseases
Worldwide Number of Diseases with Availability of Genetic
Other Diseases Neurological Diseases
Ocular Diseases Monogenic Diseases
Inflammatory Diseases Healthy Volunteers Cardiovascular Diseases
Infectious Diseases Gene Marking Cancer Diseases
2005
2006
2007
2008
2009
2010
2011E
Significant growth opportunity of genetic testing market supported by the favorable demographic trends and technological advances…
%
Growth Opportunity of European Genetic Testing Market
2011
2012E
Predictive Testing
2013E
2014E
Diagnostic Testing
2015E
Relationship Testing
Million
Projected Number of Pharmacogenetic Tests in the US
2005
2006
2007
2008
2009
The ……………………segment within the European genetic testing market is regarded more ……………. as compared to the ……………….. segments, majorly due to the ………………………………… tests. It is expected that the Y-O-Y growth rate of the market will increase to ………………..% in 2015 as compared to ………………% in 2011. However, the …………………… segment is expected to maintain …………….. Y-O-Y growth in the coming years and reach ……..% by 2015 from ………….% in 2011. The yearly growth rate of ……………. segment ……………% in 2015.
2010 2011E 2012E 2013E
Pharmacogenetics is generally regarded as ………….…… ……………………………….. gives rise to ……………… ………………... In 2005, ……………………………..million Pharmacogenetic tests were performed in the US, which increased at a CAGR of ………………………………% to reach …………………………………………………….It is expected that the overall number of Pharmacogenetic tests will reach ……………………. million by 2013, recording a CAGR of ……………% during 2010-2013.
The worldwide genetic testing market represents strong growth opportunity in coming years majorly due aging population and occurrence of genetic diseases…
US$ Billion
Worldwide Genetic Testing Market Forecast
2011A
•
2012E
2013E
2014E
2015E
The global genetic testing market has witnessed ………………..growth in the past few years, which is projected to ……………………………………..in the coming years. In 2011, the global genetic market was valued at approximately US$....................... billion, which is expected to grow up to US$.................. billion by the end of 2015. The market is estimated to grow at a CAGR of …………………% during 2011-15. The major factors to drive this growth in near future include ……………….., growing …………………….., and increasing prevalence of …………………….and ………………..
View Report Details Table of Contents
List of Charts
1. Genetic Testing: An Introduction
Classification of Molecular Diagnostics Global Molecular Diagnostics Market, 2005-2015E Global Molecular Diagnostic Market by Region, 2010 Global Genetic Testing Market, 2007-2011 Worldwide Number of Diseases with Availability of Genetic Testing, 2005-2011E Worldwide Gene Therapy Clinical Trials by Disease, 2011 Worldwide Gene Therapy Clinical Trials by Gene, 2011 Gene Therapy Clinical Trials by Country, 2011 Gene Therapy Clinical Trials by Phase, 2011 Worldwide Market for Potential Cancer Clinical Trials, 2012E-2015E Global DNA and Gene Chip Market, 2010A-2015E Global DNA Sequencing Market, 2014E Global Projected Addressable Market for Genomes, 2011E-2015E European Genetic Testing Market by Segments, 2011 Growth Opportunity of European Genetic Testing Market, 2011-2015E Projected Number of Pharmacogenetic Tests in the US, 2003-2013E Growth of Global Aging Population, 2005-2012E Global Healthcare Spending, 2005-2015E New Cases of Cancer Worldwide, 2005-2010 Market Share of Major Players in the Global Molecular Diagnostics Market, 2010 Global Life Science Industry, 2011E Market Share of Major Players in the Gene Sequencing Market, 2011 Market Share of Major Players in the Microarray Market, 2010 Share of Sales by Reportable Segments, 2011 Net Sales and Net Income of Abbott, 2007-2011 Share of Net Sales by Geographic Segments, 2011 Net Sales and Net Income of Qiagen, 2007-2011
1.1 Types of Genetic Testing 1.2 Pros and Cons of Genetic Testing 1.3 Insurance Coverage of Genetic Testing 1.4 Cost and Time Factor Associated to Genetic Testing 1.5 Procedure of Genetic Testing 1.6 Risks and Limitations of Genetic Testing 2. Global Genetic Testing Market Market Value Market Segmentation Regional Breakdown Other Market Statistics 2.1 Genetic Testing Market in Europe Market Overview Market Segmentation Growth Opportunity 2.2 Pharmacogenetics Market in the US 3. Key Trends 3.1 Strong Growth Opportunity for Carrier Genetic testing 3.2 Proactive Healthcare through DTC Genetic Testing 3.3 Legislations to Fight Genetic Discrimination in the US 4. Growth Drivers 4.1 Increasing Knowledge about Genetic Testing 4.2 Rising Ageing Population 4.3 Growing Healthcare Expenditure 4.4 Increasing Prevalence of Cancer
View Report Details 5. Significant Developments
List of Charts
5.1 Gene Scan of Alzheimer's Families Identifies Four New Suspect Genes 5.2 WARFARIN Study Launched by Iverson Genetic Diagnostics 5.3 Genzyme Introduces New Genetic Test for Lung Cancers 5.4 Clinical Data Launches Genetic Test for HCM
Share of Sales by Segments, 2011 Total Sales of Roche, 2008-2011 Quest Diagnostic’s Revenues by Business Segments, 2011 Quest Diagnostic’s Revenues and Net Income, 2006-2011 Figure 9.1: worldwide Genetic Testing Market, 2011A-2015E
6. Challenges
List of Tables
6.1 Genetic Discrimination 6.2 Psychological Consequences of Genetic Testing 6.3 Quality Concerns Related to Biochemical Genetic Testing
Dependent & Independent Variables, 2007–2011 Correlation Matrix Model Summary – Coefficient of Determination Regression Coefficients Output
7. Genetic Testing - Competitive Landscape Competitive Overview Market Share 8. Company Profile 8.1 Abbott Business Description Key Financials Business Strategies Business Diversification strategy R&D Strategy 8.2 Qiagen NV. Business Description Key Financials Business Strategies Addressing Unmet Market Needs Sales and Marketing Strategy
View Report Details 8.3 Roche Business Description Key Financials Business Strategies Delivering Personalized Healthcare Creating Sustainable Value Fostering Innovation 8.4 Quest Diagnostics Business Description Key Financials Business Strategies Continuously Drive Six Sigma Quality Leveraging Assets & Capabilities 9. Market Outlook 9.1 Market Forecast 9.2 Forecast Methodology 9.2.1 Dependent and Independent variables 9.2.2 Correlation Analysis 9.2.3 Regression Analysis
View Report Details
Contact Us:
These are abridged and sanitized sample pages from the comprehensive report on the “Global Genetic Testing Market Report”. To know more about this report or for any customized research requirement, please contact the following:
Koncept Analytics
Vikas Gupta BD Manager
CS-36, Second Floor, Ansal Plaza Vaishali, Ghaziabad, U.P. – 201010 T. +91-120-4130959 C: +91-9811715635 vikas@konceptanalytics.com
www.konceptanalytics.com